Corporate calendar for Nanobiotix S.A. (NBTX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | $0.14 | $118M |
| 2026-09-14 | $-0.06 | $36M |
| 2026-09-14 | ||
| 2026-09-14 | $-0.62 | $29M |
| 2026-09-14 | $0.10 | $672M |
Price
| Price | $34.40 |
| Market Cap | $1.7B |
| Exchange | NASDAQ |
| Country | FR |
Related companies: ABUS · EYPT · GHRS · KURA · LENZ · PROK · RZLT
Explore sector: Healthcare · Biotechnology
More sections of NBTX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks